Basilea's Head of Global Human Resources, Heidi Mc Daid, to retire and Ursula Eberhardt named as successor
(Thomson Reuters ONE) -
Basilea Pharmaceutica AG /
Basilea's Head of Global Human Resources, Heidi Mc Daid, to retire and Ursula
Eberhardt named as successor
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Basel, Switzerland, December 29, 2015 - Basilea Pharmaceutica Ltd. (SIX: BSLN)
reports today that Heidi Mc Daid, Head of Global Human Resources and member of
the management committee, will retire effective December 31, 2016.
Ronald Scott, Basilea's Chief Executive Officer, commented: "Heidi Mc Daid
joined Basilea in 2002. In her 13 years with the company, she established and
managed Basilea's Human Resources Department and provided valuable advice and
support to Basilea as it has grown. We sincerely thank Heidi for her commitment
and valuable contribution to Basilea's success throughout the years."
Ursula Eberhardt, currently Deputy Head of Basilea's Human Resources Department,
will succeed Ms Mc Daid. Ms Eberhardt has been with Basilea for nine years and
served as deputy head for the past six years.
Ronald Scott commented, "We are very pleased that Ms Eberhardt has accepted the
position of Head of Basilea's Human Resources Department effective upon Ms Mc
Daid's retirement. As Deputy Department Head, Ms Eberhardt will bring a wealth
of experience to the position."
About Basilea
Basilea Pharmaceutica Ltd. is a biopharmaceutical company developing products
that address increasing resistance and non-response to current treatment options
in the therapeutic areas of bacterial infections, fungal infections and cancer.
The company uses the integrated research, development and commercial operations
of its subsidiary Basilea Pharmaceutica International Ltd. to discover, develop
and commercialize innovative pharmaceutical products to meet the medical needs
of patients with serious and potentially life-threatening conditions. Basilea
Pharmaceutica Ltd. is headquartered in Basel, Switzerland and listed on the SIX
Swiss Exchange (SIX: BSLN). Additional information can be found at Basilea's
website www.basilea.com.
Disclaimer
This communication expressly or implicitly contains certain forward-looking
statements concerning Basilea Pharmaceutica Ltd. and its business. Such
statements involve certain known and unknown risks, uncertainties and other
factors, which could cause the actual results, financial condition, performance
or achievements of Basilea Pharmaceutica Ltd. to be materially different from
any future results, performance or achievements expressed or implied by such
forward-looking statements. Basilea Pharmaceutica Ltd. is providing this
communication as of this date and does not undertake to update any forward-
looking statements contained herein as a result of new information, future
events or otherwise.
For further information, please contact:
+-----------------------------+--------------------------------+
| Media Relations | Investor Relations |
+-----------------------------+--------------------------------+
| Peer Nils Schröder, PhD | Barbara Zink, PhD, MBA |
| Head Public Relations & | Head Corporate Development |
| Corporate Communications | |
| +41 61 606 1102 | +41 61 606 1233 |
| media_relations(at)basilea.com | investor_relations(at)basilea.com |
+-----------------------------+--------------------------------+
This press release can be downloaded from www.basilea.com.
Press release (PDF) :
http://hugin.info/134390/R/1976002/723178.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Basilea Pharmaceutica AG via GlobeNewswire
[HUG#1976002]
Unternehmensinformation / Kurzprofil:
Datum: 29.12.2015 - 07:15 Uhr
Sprache: Deutsch
News-ID 441715
Anzahl Zeichen: 4526
contact information:
Town:
Basel
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 469 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Basilea's Head of Global Human Resources, Heidi Mc Daid, to retire and Ursula Eberhardt named as successor"
steht unter der journalistisch-redaktionellen Verantwortung von
Basilea Pharmaceutica AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
